Catalyst Wire Dossier Catalyst Wire Dossier

TNS9.3.55 lentiviral vector encoding the normal human beta-globin gene

· San Rocco Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNS9.3.55 lentiviral vector encoding the normal human beta-globin gene, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: ß-Thalassemia Major With Autologous CD34+ Hematopoietic Progenitor Cells Transduced With TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene [Phase 1]

See pricing